Sigilon Therapeutics, Inc.
SGTX · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8 | -$7 | -$7 | -$9 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $1 | $1 | $1 |
| Change in WC | $0 | -$7 | -$3 | -$4 |
| Other Non-Cash | $1 | $1 | $1 | $1 |
| Operating Cash Flow | -$4 | -$11 | -$7 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7 | $0 | $43 | -$1 |
| Inv. Sales/Matur. | $7 | $13 | $18 | $10 |
| Other Inv. Act. | $0 | $0 | -$42 | $0 |
| Investing Cash Flow | -$0 | $12 | $18 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$17 | -$2 | -$2 | $0 |
| Financing Cash Flow | -$17 | -$2 | -$2 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$22 | -$1 | $9 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43 | $43 | $34 | $36 |
| End Cash | $21 | $43 | $43 | $34 |
| Free Cash Flow | -$4 | -$12 | -$7 | -$10 |